Results 91 to 100 of about 3,594 (173)

Scratching the surface: NK-1 inhibitors for chronic itch-Promise or placebo? [PDF]

J Eur Acad Dermatol Venereol
Yosipovitch G.
europepmc   +1 more source

Neuro-immune-epithelial pathways involving substance P may contribute to mucosal pathology in gastro-oesophageal reflux disease. [PDF]

Front Immunol
Leech T, Woodland P, Peiris M.
europepmc   +1 more source

Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 Pathway. [PDF]

Cancer Med
Engür-Öztürk S, Kaya-Tilki E, Dikmen M.   +2 more
europepmc   +1 more source

Structure-Based Virtual Screening and Mechanistic Characterization of Methotrexate and Selinexor as Potent Anti-Melanogenic Agents via Multi-Pathway Suppression of MITF. [PDF]

Cells
Zhang Z, Li H, Shi Z, Bai X, Yin P, Yang L.   +5 more
europepmc   +1 more source

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]

Future Oncol
Navari RM, Tyler T, Inui N, Iihara H, Bonizzoni E, Park YH, Rugo HS, Roeland EJ.   +7 more
europepmc   +1 more source

Neural signaling contributes to heart formation and growth in the invertebrate chordate, Ciona robusta. [PDF]

PLoS Biol
Gruner HN, Pickett CJ, Bao JY, Garcia R, Hozumi A, Scully TD, Popsuj S, Ning S, Gao M, Bautista G, Maze K, Lim HK, Osugi T, Collins-Doijode M, Cairns O, Levis G, Chen SY, Gong T, Satake H, Moshe Klein A, Sasakura Y, Davidson B.   +21 more
europepmc   +1 more source

A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. [PDF]

Int J Mol Sci
Kast RE, Marques Vieira B, Barros da Silva E.   +2 more
europepmc   +1 more source

Clinical guidelines highlight for the hospitalist: Management of cyclic vomiting syndrome in children. [PDF]

J Hosp Med
Hernandez YN, Gardner HM.
europepmc   +1 more source